Awareness, Practice, and Acceptance of COVID-۱۹ Vaccination among Medical Students from Mansoura University, Egypt: A Cross-sectional Survey

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 90

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_INJER-9-3_006

تاریخ نمایه سازی: 20 شهریور 1401

Abstract:

Background and aims: The coronavirus disease ۲۰۱۹ (COVID-۱۹) is an emerging transmissible infection that can be prevented by proper hygiene measures and vaccination. With the rise and rapid spread of the Omicron variant, vaccines are currently the best protective measure. This cross-sectional study aimed to assess knowledge, practice, and attitude towards COVID-۱۹ virus and vaccines, particularly Sinopharm, among medical students in Mansoura University, Egypt, from July to September ۲۰۲۱. Methods: A cross-sectional study was conducted using a ۳۵-item questionnaire covering demographic data. COVID-۱۹ knowledge/practice and knowledge/attitude towards vaccines were distributed on medical students’ university Facebook group. A score was calculated for knowledge (KS), practice (PS), and attitude (AS). A ۶۰% cutoff was considered satisfactory, and the statistical analysis was carried out using one-way ANOVA, linear regression, and Pearson’s coefficient. Results: A total of ۸۳۷ students participated in this study. The majority (۷۳.۱۲%) of participants showed satisfactory COVID-۱۹ KS and Sinopharm AS (۵۴.۷۷%) but unsatisfactory PS (۶۸.۹۹%) and Sinopharm KS (۶۲.۷۵%). Knowledge had a significant effect on Sinopharm vaccine acceptance. Moreover, females indicated higher COVID-۱۹ KS and PS, whilst males showed higher Sinopharm KS and AS. Gender and year group had a strong correlation with PS. Furthermore, the majority (۹۲.۴%) accepted vaccination and believed it should be mandatory (۸۰.۴۱%). The selected vaccines were Pfizer (۴۴.۸۴%) > AstraZeneca (۳۳.۸۶%) > Sinopharm (۱۵.۵۶%) > others. Efficacy, safety, and country of production were the main predictors of vaccine choice. More than half (۵۹.۴۸%) stated that the country in which the vaccine is produced is important when choosing their intended vaccine, and ۲۰.۸۷% stated that their decision is based on vaccine efficacy. Conclusions: COVID-۱۹ was a challenging pandemic; there are several available COVID-۱۹ vaccines, but the most available in Egypt is the Sinopharm vaccine. The results of this study will provide a basis regarding the knowledge and attitude of medical students who play a crucial part in the cycle of infection. These results will help outline the main causes of misunderstandings that can be solved by providing educational needed interventions, implementing protective measures, and distributing scientifically correct data.

Authors

Basant Katamesh

Faculty of Medicine, Tanta University, Egypt

Moustafa Katamesh

Faculty of Medicine, Tanta University, Egypt

W. Abdalrhman

Factuly of Science, Tanta University, Egypt

Rawan ElDeeb

Faculty of Medicine, Tanta University, Egypt

Nourhan Hareera

Faculty of Medicine, Tanta University, Egypt

Ahmed Raslan

Faculty of Medicine, Tanta University, Egypt

Ahmed Alabd

Factuly of Pharmacy, Tanta University, Egypt

Ensanya Abou Neel

Preventive and Restorative Dentistry Department, College of Dental Medicine, University of Sharjah, United Arab Emirates / Biomaterials Department, Faculty of Dentistry, Tanta University, Egypt / UCL Eastman Dental Institute, Biomaterials &

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Adil MT, Rahman R, Whitelaw D, Jain V, Al-Taan O, ...
  • Postgraduate Medical Journal. ۲۰۲۱;۹۷(۱۱۴۴):۱۱۰-۶ ...
  • Liu J, Liu S. The management of coronavirus disease ۲۰۱۹(COVID-۱۹). ...
  • Zhao S, Lin Q, Ran J, Musa SS, Yang G, ...
  • Preliminary estimation of the basic reproduction number ofnovel coronavirus (۲۰۱۹-nCoV) ...
  • International Journal of Infectious Diseases. ۲۰۲۰;۹۲:۲۱۴-۷ ...
  • Haidere MF, Ratan ZA, Nowroz S, Zaman SB, Jung YJ,Hosseinzadeh ...
  • Beyerstedt S, Casaro EB, Rangel ÉB. COVID-۱۹: angiotensinconvertingenzyme ۲ (ACE۲) ...
  • Awadasseid A, Wu Y, Tanaka Y, Zhang W. Current advancesin ...
  • ۲۰۲۱;۱۷(۱):۸-۱۹ ...
  • Huang Y, Yang C, Xu X-f, Xu W, Liu S-w. ...
  • Chung YH, Beiss V, Fiering SN, Steinmetz NF. COVID-۱۹ vaccine ...
  • Gao Z, Xu Y, Sun C, Wang X, Guo Y, ...
  • Chen P, Mao L, Nassis GP, Harmer P, Ainsworth BE, ...
  • Coronavirus disease (COVID-۱۹): The need to maintainregular physical activity while ...
  • Ağalar C, Öztürk Engin D. Protective measures for COVID-۱۹for healthcare ...
  • Wang H, Zhang Y, Huang B, Deng W, Quan Y, ...
  • ۲۰۲۰;۱۸۲(۳):۷۱۳-۲۱ ...
  • Rogliani P, Chetta A, Cazzola M, Calzetta L. SARS-CoV-۲neutralizing antibodies: ...
  • Xia S, Zhang Y, Wang Y, Wang H, Yang Y, ...
  • Safety and immunogenicity of an inactivated COVID-۱۹vaccine, BBIBP-CorV, in people ...
  • Ariamanesh M, Porouhan P, PeyroShabany B, Fazilat-PanahD, Dehghani M, Nabavifard ...
  • C.J. Burrell CRH, F.A. Murphy, Fenner and white’s medicalvirology,, ۲۰۱۶ ...
  • Albahri AH, Alnaqbi SA, Alnaqbi SA, Alshaali AO, ShahdoorSM. Knowledge, ...
  • Olaimat AN, Aolymat I, Shahbaz HM, Holley RA. Knowledgeand information ...
  • Jain J, Saurabh S, Kumar P, Verma MK, Goel AD, ...
  • Barello S, Nania T, Dellafiore F, Graffigna G, Caruso R ...
  • ‘Vaccine hesitancy’ among university students in Italy duringthe COVID-۱۹ pandemic. ...
  • Epub ۲۰۲۰/۰۸/۰۶ ...
  • Zahid HM, Alsayb MA. Assessing the Knowledge and Attitudetoward COVID-۱۹ ...
  • Elgendy MO, Abdelrahim MEA. Public awareness aboutcoronavirus vaccine, vaccine acceptance, ...
  • Acharya SR, Moon DH, Shin YC. Assessing attitude towardCOVID-۱۹ vaccination ...
  • Hani M. Nassar EAAN. Awareness and utilization of bulk-fillcomposites among ...
  • Chan-Yeung M, Xu R-H. SARS: epidemiology. Respirology ...
  • ۲۰۰۳;۸ Suppl(Suppl ۱):S۹-S۱۴ ...
  • Teo SP. Review of COVID-۱۹ mRNA Vaccines: BNT۱۶۲b۲and mRNA-۱۲۷۳. J ...
  • Vanaparthy R, Mohan G, Vasireddy D, Atluri P. Review ofCOVID-۱۹ ...
  • Palacios R, Patiño EG, de Oliveira Piorelli R, Conde M, ...
  • doi: ۱۰.۱۱۸۶/s۱۳۰۶۳-۰۲۰-۰۴۷۷۵-۴ ...
  • Sanders B, Koldijk M, Schuitemaker H. Inactivated viralvaccines. Vaccine Analysis: ...
  • Dadras O, Alinaghi SAS, Karimi A, MohsseniPour M,Barzegary A, Vahedi ...
  • European Journal of Medical Research. ۲۰۲۱;۲۶(۱):۶۷ ...
  • Ophinni Y, Hasibuan AS, Widhani A, Maria S, Koesnoe S,Yunihastuti ...
  • ۲۰۲۰;۵۲(۴):۳۸۸-۴۱۲ ...
  • نمایش کامل مراجع